HUP0203717A3 - Bioavailable composition containing isotretinoin and process for its preparation - Google Patents

Bioavailable composition containing isotretinoin and process for its preparation

Info

Publication number
HUP0203717A3
HUP0203717A3 HU0203717A HUP0203717A HUP0203717A3 HU P0203717 A3 HUP0203717 A3 HU P0203717A3 HU 0203717 A HU0203717 A HU 0203717A HU P0203717 A HUP0203717 A HU P0203717A HU P0203717 A3 HUP0203717 A3 HU P0203717A3
Authority
HU
Hungary
Prior art keywords
preparation
composition containing
bioavailable composition
containing isotretinoin
isotretinoin
Prior art date
Application number
HU0203717A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of HUP0203717A2 publication Critical patent/HUP0203717A2/hu
Publication of HUP0203717A3 publication Critical patent/HUP0203717A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0203717A 2000-06-16 2001-04-09 Bioavailable composition containing isotretinoin and process for its preparation HUP0203717A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN596DE2000 IN192188B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2000-06-16 2000-06-16
PCT/IB2001/000581 WO2001095886A1 (en) 2000-06-16 2001-04-09 Bioavailable dosage form of isotretinoin

Publications (2)

Publication Number Publication Date
HUP0203717A2 HUP0203717A2 (hu) 2003-04-28
HUP0203717A3 true HUP0203717A3 (en) 2003-05-28

Family

ID=11097063

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203717A HUP0203717A3 (en) 2000-06-16 2001-04-09 Bioavailable composition containing isotretinoin and process for its preparation

Country Status (25)

Country Link
US (1) US6740337B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1294357A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2004503493A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1196475C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP2002002423A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU782094B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG106414A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0106752A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2382065A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ2002694A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA004808B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE200200074A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK1052302A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20020148A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP0203717A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL148176A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN192188B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA02001669A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ517142A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA12008A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL352838A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK2252002A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA74793C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2001095886A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200201240B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2423170A1 (en) * 2000-09-22 2002-03-28 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
EP1527774A1 (en) 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
US20070099996A1 (en) * 2003-05-20 2007-05-03 Shashikanth Isloor Pharmaceutical compositions of acitretin
US20070254858A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Contraceptive and Acne Medication Combination and Treatment of Acne and Other Diseases with Reduced Side Effects
US20070254025A1 (en) * 2006-04-27 2007-11-01 Cronk Peter J Oral contraceptive and acne medication combination and treatment of acne with reduced side effects
RU2322998C1 (ru) * 2006-11-16 2008-04-27 Общество с ограниченной ответственностью "Березовый мир" Носитель лекарственных и диагностических средств
WO2008099615A1 (ja) 2007-02-16 2008-08-21 Aska Pharmaceutical Co., Ltd. 微粒子油性懸濁液を含む医薬組成物
US7763748B2 (en) * 2007-02-20 2010-07-27 Ipca Laboratories Limited Process for preparation of highly pure isotretinoin
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
MX2017015137A (es) * 2015-05-25 2018-03-28 Sun Pharmaceutical Ind Ltd Composicion farmaceutica oral de dosis diaria de isotretinoin.
WO2017203365A1 (en) 2016-05-26 2017-11-30 Dr. Reddy's Laboratiories Ltd. Pharmaceutical compositions for treating acne

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
CA1282326C (en) * 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
US4808630A (en) 1987-01-16 1989-02-28 United States Of America Method of treating psychotic illnesses
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6284283B1 (en) * 1999-10-21 2001-09-04 Alkermes Controlled Therapeutics, Inc. Method of producing sub-micron particles of biologically active agents and uses thereof

Also Published As

Publication number Publication date
BR0106752A (pt) 2002-04-16
UA74793C2 (en) 2006-02-15
US20020025338A1 (en) 2002-02-28
MXPA02001669A (es) 2002-08-06
NZ517142A (en) 2003-08-29
HUP0203717A2 (hu) 2003-04-28
IL148176A0 (en) 2002-09-12
CZ2002694A3 (cs) 2002-08-14
HK1052302A1 (zh) 2003-09-11
AP2002002423A0 (en) 2002-03-31
WO2001095886A1 (en) 2001-12-20
US6740337B2 (en) 2004-05-25
PL352838A1 (en) 2003-09-08
EA004808B1 (ru) 2004-08-26
EE200200074A (et) 2003-04-15
IN192188B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2004-03-13
ZA200201240B (en) 2002-09-02
CA2382065A1 (en) 2001-12-20
EA200200166A1 (ru) 2002-10-31
JP2004503493A (ja) 2004-02-05
AU4445901A (en) 2001-12-24
SK2252002A3 (en) 2002-08-06
AU782094B2 (en) 2005-06-30
BG106414A (en) 2002-09-30
EP1294357A1 (en) 2003-03-26
HRP20020148A2 (en) 2003-12-31
OA12008A (en) 2006-04-19
CN1196475C (zh) 2005-04-13
CN1388757A (zh) 2003-01-01

Similar Documents

Publication Publication Date Title
AU2691802A (en) Improved sucralose composition and process for its preparation
HUP0400655A3 (en) Compositions containing inclusion complexes and process for their preparation
AU2001273764A1 (en) Process for the preparation of substituted octanoyl amides
HUP0301459A3 (en) Chemical compounds process for producing them and pharmaceutical compositions containing them
HUP0102359A3 (en) Aqueous detergent composition and process for its preparation
HUP0204496A3 (en) Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same
GB0103851D0 (en) Improved packaging and process and apparatus for its manufacture
HUP0204520A3 (en) Pharmaceutical composition containing esmolol and process for its preparation
HUP0302099A3 (en) Azythromycin in the form of a monohydrate, process for its preparation and pharmaceutical composition containing in the monohydrate form
HUP0203717A3 (en) Bioavailable composition containing isotretinoin and process for its preparation
GB0126643D0 (en) Composition and process
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
GB0009877D0 (en) Granular detergent component and process for its preparation
GB0020717D0 (en) Novel compounds and process
AU8824201A (en) Process for the preparation of dinapsoline
HUP0302437A3 (en) Compositions comprising modafinil compounds and process for their preparation
IL156359A0 (en) Process for the preparation of 4-haloalkylnicotinonitriles
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
HUP0300596A3 (en) Amorphous torasemide modification, process for its preparation its use and pharmaceutical compositions containing it
AU2002221120A1 (en) Composition for texturing process
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
AU2001260607A1 (en) Nitrile compounds and process for their preparation
IL154804A0 (en) Process for the preparation of thiophenols
HU0002463D0 (en) Perfume composition complex and process for its preparation

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees